Benzimidazolone Derivatives as DGAT2 Inhibitors for Treating Diseases.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1105 West Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
出版信息
ACS Med Chem Lett. 2022 Jun 13;13(7):1004-1005. doi: 10.1021/acsmedchemlett.2c00247. eCollection 2022 Jul 14.
Abstract
摘要
相似文献
1
Benzimidazolone Derivatives as DGAT2 Inhibitors for Treating Diseases.作为用于治疗疾病的二酰甘油酰基转移酶2（DGAT2）抑制剂的苯并咪唑酮衍生物
ACS Med Chem Lett. 2022 Jun 13;13(7):1004-1005. doi: 10.1021/acsmedchemlett.2c00247. eCollection 2022 Jul 14.
2
Novel Triazolopyridine Derivatives as DGAT2 Inhibitors for Treating Multiple Diseases.作为用于治疗多种疾病的二酰甘油酰基转移酶2（DGAT2）抑制剂的新型三唑并吡啶衍生物
ACS Med Chem Lett. 2024 Aug 21;15(9):1435-1436. doi: 10.1021/acsmedchemlett.4c00408. eCollection 2024 Sep 12.
3
Novel Imidazopyridine and Imidazopyridazine Derivatives as DGAT2 Inhibitors for Treating Multiple Diseases.新型咪唑并吡啶和咪唑并哒嗪衍生物作为治疗多种疾病的二酰甘油酰基转移酶2（DGAT2）抑制剂
ACS Med Chem Lett. 2024 Jul 3;15(8):1180-1181. doi: 10.1021/acsmedchemlett.4c00286. eCollection 2024 Aug 8.
4
Towards the synthesis of new benzimidazolone derivatives with surfactant properties.
Carbohydr Res. 2008 Feb 25;343(3):421-33. doi: 10.1016/j.carres.2007.11.028. Epub 2007 Dec 5.
5
6
Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors.合成及吡唑-苯并咪唑酮杂合体的生物评价作为新型人 4-羟基苯丙酮酸双加氧酶抑制剂。
Eur J Med Chem. 2015 Mar 6;92:427-38. doi: 10.1016/j.ejmech.2015.01.018. Epub 2015 Jan 10.
7
A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs.染料木黄酮和苯并咪唑酮类似物激活囊性纤维化跨膜传导调节蛋白的共同机制。
J Pharmacol Exp Ther. 2001 Feb;296(2):464-72.
8
Mechanistic Characterization of Long Residence Time Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2).二酰基甘油酰基转移酶2（DGAT2）长停留时间抑制剂的机制表征
Biochemistry. 2018 Dec 26;57(51):6997-7010. doi: 10.1021/acs.biochem.8b01096. Epub 2018 Dec 7.
9
Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.苯并咪唑酮衍生物作为组胺 H3 受体拮抗剂的合成及构效关系研究。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):6001-3. doi: 10.1016/j.bmcl.2013.08.012. Epub 2013 Aug 13.
10
Synthesis and biological activities of some benzimidazolone derivatives.一些苯并咪唑酮衍生物的合成及生物活性
Indian J Pharm Sci. 2015 Mar-Apr;77(2):230-6. doi: 10.4103/0250-474x.156619.
引用本文的文献
1
Novel Imidazopyridine and Imidazopyridazine Derivatives as DGAT2 Inhibitors for Treating Multiple Diseases.新型咪唑并吡啶和咪唑并哒嗪衍生物作为治疗多种疾病的二酰甘油酰基转移酶2（DGAT2）抑制剂
ACS Med Chem Lett. 2024 Jul 3;15(8):1180-1181. doi: 10.1021/acsmedchemlett.4c00286. eCollection 2024 Aug 8.
2
The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7.miR-26 在动脉粥样硬化中的转译潜力及其靶基因 ACC1/2、COL1A1、CPT1A、FBP1、DGAT2 和 SMAD7 相关药物的研发。
Cardiovasc Diabetol. 2024 Jan 9;23(1):21. doi: 10.1186/s12933-024-02119-z.
本文引用的文献
1
High-density lipoproteins (HDL): Novel function and therapeutic applications.高密度脂蛋白（HDL）：新功能与治疗应用。
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Jan;1867(1):159058. doi: 10.1016/j.bbalip.2021.159058. Epub 2021 Oct 5.
2
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer.为癌症机器加油：脂质代谢在癌症中的作用。
Cell Metab. 2020 Jan 7;31(1):62-76. doi: 10.1016/j.cmet.2019.11.010. Epub 2019 Dec 5.
Zotero 插件